PLOD2 and neoplasm: Fifty percent (19/38) of tumor tissue samples showed positive staining for PLOD2, with 74% of the samples displaying preferential staining of cells at the invasive front of the tumor tissue (Figure 6B,E, blue arrow) and 26% stained throughout the tumor tissue (Figure 6C,F).